Main Sessions


Trials and tribulations in the development of medical therapies

Tuesday 13 September 09:00 - 11:00

Co-chairs: Christian Elger (Germany), Jacqueline French (USA)

Seizure counting and its consequences for clinical trials in epilepsies - Christian Elger (Germany)

Relationships between efficacy and placebo rates – Sylvain Rheims (France)

Open vs. blinded trials in epilepsy – Tony Marson (United Kingdom)

Monotherapy trials in epilepsy: are they necessary and how should they be designed? - Jacqueline French (USA)


Neurogenesis in epilepsy

Wednesday 13 September 09:00 - 11:00

Co-chairs: Hana Kubova (Czech Republic), Helen Scharfman (USA)

Adult neurogenesis: from genes to brain function – Sebastian Jessberger (Switzerland)

Neurogenesis in epileptic brain: possible target for therapy? - Helen Scharfman (USA)

Neurogenesis in epileptic brain: does it contribute to epileptic comorbidities? - Gerd Kempermann (Germany)

Does neurogenesis happen in the human brain? – Embla Steiner (Sweden)


Challenges in the management of epilepsy in children – systems and technology as solutions

Wednesday 14 September 09:00 - 11:00

Co-chairs: Sameer Zuberi (United Kingdom), Lieven Lagae (Belgium)

Clinical networks – breaking barriers between primary, secondary and tertiary care - Sameer Zuberi (United Kingdom)

The internet, apps and social media – education, interaction and management – Kate Riney (Australia)

Guidelines, pathways and checklists – raising standards or preventing personalized care? – Dana Craiu (Romania)

Alarms & monitors – distractions or life savers? – Lieven Lagae (Belgium)


The changing landscape of epilepsy surgery: assessment and treatment

Tuesday 13 September 09:00 - 11:00

Co-chairs: Margitta Seeck (Switzerland), Petr Marusic (Czech Republic)

The true outcome of surgical therapy in the 21st century in Europe - Margitta Seeck (Switzerland)

Why don’t patients get epilepsy surgery? – Eva Kumlien (Sweden)

Antiepileptic drug withdrawal after epilepsy surgery – Kees Braun (The Netherlands)

The future of epilepsy surgery techniques – Karl Schaller (Switzerland)